On March 15, 2023 Targovax ASA (OSE: TRVX) reported that an abstract describing its circular RNA platform has been accepted for poster presentation at the 2023 American Association for Cancer Research (AACR) (Free AACR Whitepaper) Annual Meeting in Orlando, USA (Press release, Targovax, MAR 15, 2023, View Source [SID1234628800]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The abstract describes the advantage of protein expression utilizing Targovax´proprietary circAde vector system. By comparing protein expression from circRNA and mRNA-based vectors, it is shown that the circAde-system out-performs conventional mRNA-based designs, both in terms of protein expression level and durability. Persistent and prolonged protein expression in patients is expected to result in positive treatment outcomes. The results thus highlight the circAde platform’s potential for development of novel, more effective medicines for the treatment of cancer and other diseases.

The abstract has been released on the AACR (Free AACR Whitepaper) website (View Source!/10828/presentation/5271). The poster is scheduled for presentation Tuesday 18 April 2023 and will be available on Targovax’s website after the presentation.

Poster title: circAde: a circRNA-based system for prolonged and more effective treatment of cancer
Date and time: Tuesday 18 April 2023, 13:30- 17:00 CDT / 20:30-24:00 CET
Location: Orange County Convention Center, Orlando, Florida
Session title: High-throughput Screening, Lead Identification and Optimization, and in Silico Drug Discovery
Poster number: 5335 / 17
Presenter: Thomas Birkballe Hansen, VP Research, Targovax
About AACR (Free AACR Whitepaper)

The AACR (Free AACR Whitepaper) Annual Meeting is the focal point of the cancer research community, where scientists, clinicians, other health care professionals, survivors, patients, and advocates gather to share the latest advances in cancer science and medicine. From population science and prevention; to cancer biology, translational, and clinical studies; to survivorship and advocacy; the AACR (Free AACR Whitepaper) Annual Meeting highlights the work of the best minds in cancer research from institutions all over the world.

For further information, please contact:
Erik Digman Wiklund, CEO
Phone: +47 413 33 536
Email: [email protected]

Renate Birkeli, Investor Relations
Phone: +47 922 61 624
Email: [email protected]

Media enquires:
Andreas Tinglum – Corporate Communications (Norway)
Phone: +47 9300 1773
Email: [email protected]